Cytokine receptor Flashcards

1
Q

What are the effector properties of cytokines

A

Pleiotropic(diff effects on diff types of target cells)
- Redundancy (multiple cytokines hv same effect)
- synergistics (cooperative effect)
- antagonistic (inhibition by one another)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How many classes in cytokine recep

A

I (classical), II (TNF), III (IL-1)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

TNF full form

A

tumour necrosis factor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How many types of class I cytokine recep

A

Type I and II

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How many types of type I classical

A
  • Single chain recep fml
  • Common y chain recess fml
  • Gp130 recep fml
  • common Bchain recep fml
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Exp of type I single chain recep

A

Erythropoietin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Exp of type I common ychain recep

A

IL-2 fml + IL-4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Exp of type I Gp130 recep

A

IL-6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Exp of type 1 Bchain recep

A

IL-5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Exp of Type II classical recep

A

IFNy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Diff btw type I and II classical

A

Type I has conserved WSXWS motif on extracellular domain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How classical cytokine recep activated by erythropoietin

A

dimerisation, JAK-STAT pathway activated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What happen when erythropoietin recep ACTIVATED

A

JAK-2 phosphorylates Tyr on intracellular domain of EpoR
- Activated Tyr as docking sites of STAT5 via its SH2 domain
- STAT5 phosphorylated by JAK2, form dimers
- STAT5 activates gen transcription

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Tm for Rheumatoid arthritis

A

Oral Tofacitinib high potency in inhibiting JAK1 & 3, prevent STAT translocation into nucleus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Tofacitinib side effect

A
  • Increased risk of shingles infection
  • Anaemia, when JAK2 activity affected
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

JAK-1 specific inhibitor

A

Abrocitinib

17
Q

JAK-STAT regulation

A
  • SHP-1 removes P from JAK
  • PIAS binds to activated STAT prevent DNA binding
  • SOCS produced by STAT activated gene transcription, binds to Tyr-P on JAK/receptor
  • SUMO binds to STAT affect its stability
18
Q

Exp of Class II (TNFR)

A

TNFR1, RANK

19
Q

RANK full form

A

Receptor activator of NF-kappaB

20
Q

Ligand of TNF1 and RANK

A

TNFa, RANKL

21
Q

What are the two pathways TNFR1 can activate

A

Inflammatory and death-inducing

22
Q

Pathways of inflammatory TNFR1

A

MAPK activation, NF-kappaB activation

23
Q

Pathway of death-inducing pathway of TNFR1

A

Pro-caspase 8/10 activation

24
Q
A